Colinz Laboratories declared their Q3 FY24 results on 31 Jan, 2024. The topline increased by 2.08% & the profit increased by 3.61% YoY. As compared to the previous quarter, the revenue declined by 4.01% and the profit decreased by 13.72%.
The Selling, general & administrative expenses declined by 4.97% q-o-q & decreased by 0.61% Y-o-Y.
The operating income was up by 15.64% q-o-q & increased by 5.13% Y-o-Y.
The EPS is ₹0.42 for Q3 FY24 which increased by 2.44% Y-o-Y.
Colinz Laboratories has delivered 2.1% return in the last 1 week, 8.83% return in the last 6 months, and -0.12% YTD return.
Currently, Colinz Laboratories has a market cap of ₹10.06 Cr and a 52wk high/low of ₹44 & ₹33.35 respectively.
| Period | Q3 FY24 | Q2 FY24 | Q-o-Q Growth | Q3 FY23 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 1.71 | 1.79 | -4.01% | 1.68 | +2.08% |
| Selling/ General/ Admin Expenses Total | 0.76 | 0.8 | -4.97% | 0.77 | -0.61% |
| Depreciation/ Amortization | 0.03 | 0.03 | -0% | 0.03 | +1.24% |
| Total Operating Expense | 1.61 | 1.69 | -5.11% | 1.58 | +1.88% |
| Operating Income | 0.11 | 0.09 | +15.64% | 0.1 | +5.13% |
| Net Income Before Taxes | 0.15 | 0.16 | -8.96% | 0.13 | +10.33% |
| Net Income | 0.11 | 0.12 | -13.72% | 0.1 | +3.61% |
| Diluted Normalized EPS | 0.42 | 0.49 | -14.12% | 0.41 | +2.44% |
FAQs
Question : What is the Q3 FY24 profit/Loss as per company?
Ans : ₹0.11Cr
Question : What is Q3 FY24 revenue?
Ans : ₹1.71Cr
Stay updated on quarterly results with our results calendar
Here’s your comprehensive 3-minute summary of all the things Finance Minister Nirmala Sitharaman said in her Budget speech: Click to download!
Download The Mint News App to get Daily Market Updates & Live Business News.
Published: 03 Feb 2024, 02:43 AM IST